Evangelopoulos Michael, Parodi Alessandro, Martinez Jonathan O, Tasciotti Ennio
Center for Biomimetic Medicine, Houston Methodist Research Institute, Houston, TX 77030, USA.
Department of Pharmacology, University of Illinois at Chicago, Chicago, IL 60607, USA.
Nanomaterials (Basel). 2018 Aug 21;8(9):637. doi: 10.3390/nano8090637.
Over the years, imaging and therapeutic modalities have seen considerable progress as a result of advances in nanotechnology. Theranostics, or the marrying of diagnostics and therapy, has increasingly been employing nano-based approaches to treat cancer. While first-generation nanoparticles offered considerable promise in the imaging and treatment of cancer, toxicity and non-specific distribution hindered their true potential. More recently, multistage nanovectors have been strategically designed to shield and carry a payload to its intended site. However, detection by the immune system and sequestration by filtration organs (i.e., liver and spleen) remains a major obstacle. In an effort to circumvent these biological barriers, recent trends have taken inspiration from biology. These bioinspired approaches often involve the use of biologically-derived cellular components in the design and fabrication of biomimetic nanoparticles. In this review, we provide insight into early nanoparticles and how they have steadily evolved to include bioinspired approaches to increase their theranostic potential.
多年来,由于纳米技术的进步,成像和治疗方式取得了显著进展。治疗诊断学,即诊断与治疗的结合,越来越多地采用基于纳米的方法来治疗癌症。虽然第一代纳米颗粒在癌症成像和治疗方面展现出了巨大潜力,但毒性和非特异性分布阻碍了它们发挥真正的潜能。最近,多级纳米载体经过精心设计,能够保护并将有效载荷运送到目标部位。然而,被免疫系统检测到以及被过滤器官(即肝脏和脾脏)截留仍然是一个主要障碍。为了规避这些生物屏障,近期的趋势从生物学中汲取了灵感。这些受生物启发的方法通常涉及在仿生纳米颗粒的设计和制造中使用生物衍生的细胞成分。在这篇综述中,我们深入探讨了早期的纳米颗粒,以及它们如何逐步发展到纳入受生物启发的方法以提高其治疗诊断潜力。